Selected research
Industry Research
CAR-T Cell Service Industry Research Report 2026
Market perspective
The global CAR-T Cell Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the CAR-T Cell Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the CAR-T Cell Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the CAR-T Cell Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of CAR-T Cell Service include Aurigene Pharmaceutical Services Ltd, Cellipont Bioservices, ProBio, Creative Biolabs, Charles River Laboratories, Cytiva, Sino Biological, Inc, Miltenyi Biotec and ProMab Biotechnologies, Inc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global CAR-T Cell Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to CAR-T Cell Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
CAR-T Cell Service Market by Company
Aurigene Pharmaceutical Services Ltd
Cellipont Bioservices
ProBio
Creative Biolabs
Charles River Laboratories
Cytiva
Sino Biological, Inc
Miltenyi Biotec
ProMab Biotechnologies, Inc
Creative Biogene
BPS Bioscience, Inc
Reaction Biology
Cusabio Technology LLC
Oncodesign Services
ACROBiosystems
Kite Pharma, Inc
sartorius
WuXi ATU Co
CAR-T Cell Service Segment by Type
Development Services
Manufacturing Services
Other
CAR-T Cell Service Segment by Application
Clinical Research
Clinical Treatment
Other
CAR-T Cell Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CAR-T Cell Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CAR-T Cell Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CAR-T Cell Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of CAR-T Cell Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Development Services
- Manufacturing Services
- Other
Applications
- Clinical Research
- Clinical Treatment
- Other
Companies covered
- Aurigene Pharmaceutical Services Ltd
- Cellipont Bioservices
- ProBio
- Creative Biolabs
- Charles River Laboratories
- Cytiva
- Sino Biological, Inc
- Miltenyi Biotec
- ProMab Biotechnologies, Inc
- Creative Biogene
- BPS Bioscience, Inc
- Reaction Biology
- Cusabio Technology LLC
- Oncodesign Services
- ACROBiosystems
- Kite Pharma, Inc
- sartorius
- WuXi ATU Co
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 CAR-T Cell Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Development Services
- 2.2.3 Manufacturing Services
- 2.2.4 Other
- 2.3 CAR-T Cell Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Research
- 2.3.3 Clinical Treatment
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 CAR-T Cell Service Breakdown Data by Type
- 3.1 Global CAR-T Cell Service Historic Market Size by Type (2021-2026)
- 3.2 Global CAR-T Cell Service Forecasted Market Size by Type (2027-2032)
4 CAR-T Cell Service Breakdown Data by Application
- 4.1 Global CAR-T Cell Service Historic Market Size by Application (2021-2026)
- 4.2 Global CAR-T Cell Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global CAR-T Cell Service Market Perspective (2021-2032)
- 5.2 Global CAR-T Cell Service Growth Trends by Region
- 5.2.1 Global CAR-T Cell Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 CAR-T Cell Service Historic Market Size by Region (2021-2026)
- 5.2.3 CAR-T Cell Service Forecasted Market Size by Region (2027-2032)
- 5.3 CAR-T Cell Service Market Dynamics
- 5.3.1 CAR-T Cell Service Industry Trends
- 5.3.2 CAR-T Cell Service Market Drivers
- 5.3.3 CAR-T Cell Service Market Challenges
- 5.3.4 CAR-T Cell Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top CAR-T Cell Service Players by Revenue
- 6.1.1 Global Top CAR-T Cell Service Players by Revenue (2021-2026)
- 6.1.2 Global CAR-T Cell Service Revenue Market Share by Players (2021-2026)
- 6.2 Global CAR-T Cell Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of CAR-T Cell Service Head Office and Area Served
- 6.4 Global CAR-T Cell Service Players, Product Type & Application
- 6.5 Global CAR-T Cell Service Manufacturers Established Date
- 6.6 Global CAR-T Cell Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America CAR-T Cell Service Market Size (2021-2032)
- 7.2 North America CAR-T Cell Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America CAR-T Cell Service Market Size by Country (2021-2026)
- 7.4 North America CAR-T Cell Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe CAR-T Cell Service Market Size (2021-2032)
- 8.2 Europe CAR-T Cell Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe CAR-T Cell Service Market Size by Country (2021-2026)
- 8.4 Europe CAR-T Cell Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific CAR-T Cell Service Market Size (2021-2032)
- 9.2 Asia-Pacific CAR-T Cell Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific CAR-T Cell Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific CAR-T Cell Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America CAR-T Cell Service Market Size (2021-2032)
- 10.2 South America CAR-T Cell Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America CAR-T Cell Service Market Size by Country (2021-2026)
- 10.4 South America CAR-T Cell Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa CAR-T Cell Service Market Size (2021-2032)
- 11.2 Middle East & Africa CAR-T Cell Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa CAR-T Cell Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa CAR-T Cell Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Aurigene Pharmaceutical Services Ltd
- 12.1.1 Aurigene Pharmaceutical Services Ltd Company Information
- 12.1.2 Aurigene Pharmaceutical Services Ltd Business Overview
- 12.1.3 Aurigene Pharmaceutical Services Ltd Revenue in CAR-T Cell Service Business (2021-2026)
- 12.1.4 Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Product Portfolio
- 12.1.5 Aurigene Pharmaceutical Services Ltd Recent Developments
- 12.2 Cellipont Bioservices
- 12.2.1 Cellipont Bioservices Company Information
- 12.2.2 Cellipont Bioservices Business Overview
- 12.2.3 Cellipont Bioservices Revenue in CAR-T Cell Service Business (2021-2026)
- 12.2.4 Cellipont Bioservices CAR-T Cell Service Product Portfolio
- 12.2.5 Cellipont Bioservices Recent Developments
- 12.3 ProBio
- 12.3.1 ProBio Company Information
- 12.3.2 ProBio Business Overview
- 12.3.3 ProBio Revenue in CAR-T Cell Service Business (2021-2026)
- 12.3.4 ProBio CAR-T Cell Service Product Portfolio
- 12.3.5 ProBio Recent Developments
- 12.4 Creative Biolabs
- 12.4.1 Creative Biolabs Company Information
- 12.4.2 Creative Biolabs Business Overview
- 12.4.3 Creative Biolabs Revenue in CAR-T Cell Service Business (2021-2026)
- 12.4.4 Creative Biolabs CAR-T Cell Service Product Portfolio
- 12.4.5 Creative Biolabs Recent Developments
- 12.5 Charles River Laboratories
- 12.5.1 Charles River Laboratories Company Information
- 12.5.2 Charles River Laboratories Business Overview
- 12.5.3 Charles River Laboratories Revenue in CAR-T Cell Service Business (2021-2026)
- 12.5.4 Charles River Laboratories CAR-T Cell Service Product Portfolio
- 12.5.5 Charles River Laboratories Recent Developments
- 12.6 Cytiva
- 12.6.1 Cytiva Company Information
- 12.6.2 Cytiva Business Overview
- 12.6.3 Cytiva Revenue in CAR-T Cell Service Business (2021-2026)
- 12.6.4 Cytiva CAR-T Cell Service Product Portfolio
- 12.6.5 Cytiva Recent Developments
- 12.7 Sino Biological, Inc
- 12.7.1 Sino Biological, Inc Company Information
- 12.7.2 Sino Biological, Inc Business Overview
- 12.7.3 Sino Biological, Inc Revenue in CAR-T Cell Service Business (2021-2026)
- 12.7.4 Sino Biological, Inc CAR-T Cell Service Product Portfolio
- 12.7.5 Sino Biological, Inc Recent Developments
- 12.8 Miltenyi Biotec
- 12.8.1 Miltenyi Biotec Company Information
- 12.8.2 Miltenyi Biotec Business Overview
- 12.8.3 Miltenyi Biotec Revenue in CAR-T Cell Service Business (2021-2026)
- 12.8.4 Miltenyi Biotec CAR-T Cell Service Product Portfolio
- 12.8.5 Miltenyi Biotec Recent Developments
- 12.9 ProMab Biotechnologies, Inc
- 12.9.1 ProMab Biotechnologies, Inc Company Information
- 12.9.2 ProMab Biotechnologies, Inc Business Overview
- 12.9.3 ProMab Biotechnologies, Inc Revenue in CAR-T Cell Service Business (2021-2026)
- 12.9.4 ProMab Biotechnologies, Inc CAR-T Cell Service Product Portfolio
- 12.9.5 ProMab Biotechnologies, Inc Recent Developments
- 12.10 Creative Biogene
- 12.10.1 Creative Biogene Company Information
- 12.10.2 Creative Biogene Business Overview
- 12.10.3 Creative Biogene Revenue in CAR-T Cell Service Business (2021-2026)
- 12.10.4 Creative Biogene CAR-T Cell Service Product Portfolio
- 12.10.5 Creative Biogene Recent Developments
- 12.11 BPS Bioscience, Inc
- 12.11.1 BPS Bioscience, Inc Company Information
- 12.11.2 BPS Bioscience, Inc Business Overview
- 12.11.3 BPS Bioscience, Inc Revenue in CAR-T Cell Service Business (2021-2026)
- 12.11.4 BPS Bioscience, Inc CAR-T Cell Service Product Portfolio
- 12.11.5 BPS Bioscience, Inc Recent Developments
- 12.12 Reaction Biology
- 12.12.1 Reaction Biology Company Information
- 12.12.2 Reaction Biology Business Overview
- 12.12.3 Reaction Biology Revenue in CAR-T Cell Service Business (2021-2026)
- 12.12.4 Reaction Biology CAR-T Cell Service Product Portfolio
- 12.12.5 Reaction Biology Recent Developments
- 12.13 Cusabio Technology LLC
- 12.13.1 Cusabio Technology LLC Company Information
- 12.13.2 Cusabio Technology LLC Business Overview
- 12.13.3 Cusabio Technology LLC Revenue in CAR-T Cell Service Business (2021-2026)
- 12.13.4 Cusabio Technology LLC CAR-T Cell Service Product Portfolio
- 12.13.5 Cusabio Technology LLC Recent Developments
- 12.14 Oncodesign Services
- 12.14.1 Oncodesign Services Company Information
- 12.14.2 Oncodesign Services Business Overview
- 12.14.3 Oncodesign Services Revenue in CAR-T Cell Service Business (2021-2026)
- 12.14.4 Oncodesign Services CAR-T Cell Service Product Portfolio
- 12.14.5 Oncodesign Services Recent Developments
- 12.15 ACROBiosystems
- 12.15.1 ACROBiosystems Company Information
- 12.15.2 ACROBiosystems Business Overview
- 12.15.3 ACROBiosystems Revenue in CAR-T Cell Service Business (2021-2026)
- 12.15.4 ACROBiosystems CAR-T Cell Service Product Portfolio
- 12.15.5 ACROBiosystems Recent Developments
- 12.16 Kite Pharma, Inc
- 12.16.1 Kite Pharma, Inc Company Information
- 12.16.2 Kite Pharma, Inc Business Overview
- 12.16.3 Kite Pharma, Inc Revenue in CAR-T Cell Service Business (2021-2026)
- 12.16.4 Kite Pharma, Inc CAR-T Cell Service Product Portfolio
- 12.16.5 Kite Pharma, Inc Recent Developments
- 12.17 sartorius
- 12.17.1 sartorius Company Information
- 12.17.2 sartorius Business Overview
- 12.17.3 sartorius Revenue in CAR-T Cell Service Business (2021-2026)
- 12.17.4 sartorius CAR-T Cell Service Product Portfolio
- 12.17.5 sartorius Recent Developments
- 12.18 WuXi ATU Co
- 12.18.1 WuXi ATU Co Company Information
- 12.18.2 WuXi ATU Co Business Overview
- 12.18.3 WuXi ATU Co Revenue in CAR-T Cell Service Business (2021-2026)
- 12.18.4 WuXi ATU Co CAR-T Cell Service Product Portfolio
- 12.18.5 WuXi ATU Co Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst